Tang Justine, Chen Li-Ru, Chen Kuo-Hu
School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Department of Physical Medicine and Rehabilitation, Mackay Memorial Hospital, Taipei 104, Taiwan.
Pharmaceuticals (Basel). 2021 Dec 29;15(1):46. doi: 10.3390/ph15010046.
Dehydroepiandrosterone (DHEA), and its metabolite, dehydroepiandrosterone sulfate ester (DHEAS), are the most abundant circulating steroid hormones, and are synthesized in the zona reticularis of the adrenal cortex, in the gonads, and in the brain. The precise physiological role of DHEA and DHEAS is not yet fully understood, but these steroid hormones can act as androgens, estrogens, and neurosteroids, and perform many roles in the human body. Since both levels decline with age, use of DHEA supplements have gained more attention due to being advertised as an antidote to aging in postmenopausal women, who may have concerns on age-related diseases and overall well-being. However, current research has not reached an overall consensus on the effects of DHEA on postmenopausal women. This overview is a summary of the current literature, addressing the metabolic pathway for DHEA synthesis and utilization, as well as the effects of DHEA on premenopausal and postmenopausal women with disease states and other factors. As for the therapeutic effects on menopausal syndrome and other age-related diseases, several studies have found that DHEA supplementations can alleviate vasomotor symptoms, preserve the integrity of the immune system, reduce bone loss, and increase muscle mass. Intravaginal DHEA has shown significant beneficial effects in menopausal women with severe vulvovaginal symptoms. On the other hand, DHEA supplements have not shown definitive effects in cardiovascular disease, adrenal insufficiency, insulin sensitivity, and cognition. Due to inadequate sample sizes and treatment durations of current studies, it is difficult to assess the safety and efficacy of DHEA and draw reliable conclusions for the physiological role, the optimal dosage, and the effects on premenopausal and postmenopausal women; therefore, the study of DHEA warrants future investigation. Further research into the roles of these steroid hormones may bring us closer to a therapeutic option in the future.
脱氢表雄酮(DHEA)及其代谢产物硫酸脱氢表雄酮(DHEAS)是循环中最丰富的甾体激素,在肾上腺皮质网状带、性腺和大脑中合成。DHEA和DHEAS的确切生理作用尚未完全明确,但这些甾体激素可作为雄激素、雌激素和神经甾体发挥作用,并在人体中执行多种功能。由于两者的水平均随年龄增长而下降,DHEA补充剂的使用因被宣传为绝经后女性抗衰老的解药而受到更多关注,这些女性可能对与年龄相关的疾病和整体健康状况有所担忧。然而,目前的研究尚未就DHEA对绝经后女性的影响达成总体共识。本综述是对当前文献的总结,阐述了DHEA合成和利用的代谢途径,以及DHEA对患有疾病状态和其他因素的绝经前和绝经后女性的影响。至于对更年期综合征和其他与年龄相关疾病的治疗效果,多项研究发现,补充DHEA可缓解血管舒缩症状、维持免疫系统的完整性、减少骨质流失并增加肌肉量。阴道内使用DHEA已显示对有严重外阴阴道症状的绝经后女性有显著益处。另一方面,DHEA补充剂在心血管疾病、肾上腺功能不全、胰岛素敏感性和认知方面尚未显示出明确效果。由于当前研究的样本量和治疗持续时间不足,难以评估DHEA的安全性和有效性,也难以就其生理作用、最佳剂量以及对绝经前和绝经后女性的影响得出可靠结论;因此,DHEA的研究值得未来进一步探索。对这些甾体激素作用的进一步研究可能会使我们在未来更接近一种治疗选择。